These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18776152)

  • 21. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM; Culler SD; Ershoff D; Gutierrez B
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-acting beta-agonists plus inhaled corticosteroids safety: a systematic review and meta-analysis of non-randomized studies.
    Hernández G; Avila M; Pont A; Garin O; Alonso J; Laforest L; Cates CJ; Ferrer M;
    Respir Res; 2014 Jul; 15(1):83. PubMed ID: 25038591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is it safe to use long-acting beta-agonists in asthma and chronic obstructive pulmonary disease? Implications of recent trials and meta-analyses.
    Sears MR
    Pol Arch Med Wewn; 2008 Dec; 118(12):761-6. PubMed ID: 19202956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safe use of long-acting β-agonists: what have we learnt?
    Sears MR
    Expert Opin Drug Saf; 2011 Sep; 10(5):767-78. PubMed ID: 21521133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The future of the long-acting beta-adrenergic bronchodilators in the treatment of asthma.
    Mansfield LE
    Allergy Asthma Proc; 2008; 29(2):103-8. PubMed ID: 18430306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacoepidemiological Study of Long-Acting β-agonist/Inhaled Corticosteroid Therapy and Asthma Mortality: Clinical Implications.
    Camargo CA; Davis KJ; Andrews EB; Stempel DA; Schatz M
    Clin Drug Investig; 2016 Dec; 36(12):993-999. PubMed ID: 27581247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews.
    Walters JA; Wood-Baker R; Walters EH
    Respir Med; 2005 Apr; 99(4):384-95. PubMed ID: 15763443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety of long-acting beta agonists and inhaled corticosteroids in children and adolescents with asthma.
    Xia Y; Kelton CM; Xue L; Guo JJ; Bian B; Wigle PR
    Ther Adv Drug Saf; 2013 Dec; 4(6):254-63. PubMed ID: 25114786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma.
    Hartling L; Bond K; Vandermeer B; Seida J; Dryden DM; Rowe BH
    PLoS One; 2011 Feb; 6(2):e17242. PubMed ID: 21390219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential risks of using LABAs with ICS therapy.
    Beasley R; Wijesinghe M; Weatherall M
    Am J Respir Crit Care Med; 2009 Sep; 180(6):581; author reply 581-2. PubMed ID: 19734352
    [No Abstract]   [Full Text] [Related]  

  • 34. [Safety with use of long-acting β₂-selective agonists for asthma].
    Solnør LS; Skeie ØS; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2019 Nov; 139(17):. PubMed ID: 31746168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions.
    Lu CY; Hou L; Kolonoski J; Petrone AB; Zhang F; Corey C; Huang TY; Bradley MC
    Pharmacoepidemiol Drug Saf; 2023 Mar; 32(3):298-311. PubMed ID: 36331361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The nature and influence of pharmaceutical industry involvement in asthma trials.
    Bond K; Spooner C; Tjosvold L; Lemière C; Rowe BH
    Can Respir J; 2012; 19(4):267-71. PubMed ID: 22891187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are inhaled long-acting Beta-agonists (laba) really harmful in adult asthmatics?
    Khajotia R; Tnew C
    Malays Fam Physician; 2008; 3(2):98-100. PubMed ID: 25606126
    [No Abstract]   [Full Text] [Related]  

  • 38. Review of 'Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.' Salpeter SR, Buckley NS, Ormiston TM, Salpeter EE. Ann Intern Med 2006;144:904-12.
    Kaplan A
    Prim Care Respir J; 2006 Oct; 15(5):313-314. PubMed ID: 31700392
    [No Abstract]   [Full Text] [Related]  

  • 39. Correction to: Efficacy and safety of adjunctive corticosteroids in the treatment of severe community‑acquired pneumonia: a systematic review and meta‑analysis of randomized controlled trials.
    Wu JY; Tsai YW; Hsu WH; Liu TH; Huang PY; Chuang MH; Liu MY; Lai CC
    Crit Care; 2023 Oct; 27(1):411. PubMed ID: 37891660
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.